Euan Richards

Organic Chemistry, High-Throughput Screening, Bioinformatics & Cheminformatics

I am a multidisciplinary researcher combining computational chemical library design, synthetic organic chemistry, and high-throughput phenotypic screening.

My work focuses on leveraging chemical library design to increase the efficiency of high-throughput target agnostic phenotypic screens including bioinformatic deconvolution, for novel therapeutic discovery.

Euan Richards

Education

PhD in Chemistry

ETH Zurich, Switzerland • 2020 - 2026

Research Group of Professor Jeffrey W. Bode

Thesis: Development of on-demand chemical libraries for high-content phenotypic screening.

Industrial Thesis

Bicycle Therapeutics, Cambridge, UK • 2018 - 2019

MChem in Chemistry

Durham University, UK • 2015 - 2019

First class honours.

Experience

Student Research Associate

Bicycle Therapeutics • 2018 - 2019

  • Designing of novel scaffolds for Bicycle Therapeutics’ bicyclic peptide platform
  • Optimisation of an MT1-MMP targeting bicyclic peptide (SAR and physicochemical properties) leading to a patent

Skills

Organic Synthesis • High-Throughput Screening • Cell Painting • Cheminformatics • Bioinformatics • Machine Learning

Publications, Patents & Talks

  • Publication (Manuscript in preparation): On-Demand Chemical Libraries for High-Content ScreeningRichards, E.; O'Hare, S.; Götz, J.; Bode, J.
  • Publication (Manuscript in preparation): Chemical library generation and peptide modification from Aminopyridine N-oxides and potassium acyltrifloroboratesSchilling, P.; Richards, E.; Bode, J.
  • Publication (Under Review): Precision Oncology: Advancing Cancer Radiotheranostics with the Novel MT1-MMP-Targeting Bicyclic Peptide BCY25286Eder, A. Regupathy, A., Fakiri, M, E., Lahdenranta. J, Domogalla, L. Wood, F. Steinacker, N. Blakeman, B. Uhlmann, L. Sulewska, M. Richards, E. Lani, R. Chen, L. Bennett, G, S. Meyer P, T. Mudd G, E. Eder, M.
  • Publication (Science Advances): Predicting three-component reaction outcomes from ~40,000 miniaturized reactant combinationsGötz, J.; Richards, E.; Stepek, I.; Takahashi, Y.; Huang, Y.-L.; Bertschi, L.; Rubi, B.; Bode, J.
  • Patent (Bicycle Therapeutics): Bicyclic Peptide Ligands Specific for Mt1-Mmp (US2022024982A1, 2022).Inventors: Chen, L.; Richards, E.; Lani, R.; Mudd, G.; Stace, C.; Teufel, D.; Walker, E.
  • Talk: "Enabling an On-Demand Drug Library with High Throughput Synthesis and Cheminformatics" - Gordon Research Seminar, U.S. (2023).
  • References: Available upon request.

Other Accomplishments